I'm LongbridgeAI, I can summarize articles.UBS analyst Peter Grom reaffirmed a Buy rating on Procter & Gamble (PG) with a $172 price target, citing attractive valuation and improving consumption trends. Despite expecting near-term earnings slightly below consensus, Grom sees upside potential for FY27 growth. J.P. Morgan also maintained a Buy rating with a $162 target.
Procter & Gamble, the Consumer Defensive sector company, was revisited by a Wall Street analyst today. Analyst Peter Grom from UBS maintained a Buy rating on the stock and has a $172.00 price target.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Peter Grom has given his Buy rating due to a combination of factors, including resilient underlying demand and an attractive valuation setup. While he expects near‑term earnings and organic sales to come in slightly below consensus, he views the current reset in expectations and the company’s improving consumption trends as laying the groundwork for faster organic growth into FY27. He also highlights that PG’s share performance has trailed key home and personal care peers year‑to‑date, which, combined with solid fundamentals, creates upside skew in the risk/reward profile.
Looking ahead, Grom anticipates FY27 guidance to mirror the current year’s conservative tone, with low single‑digit organic growth and modest operating leverage, but sees this prudence as increasing the potential for positive surprises. He notes that cost pressures should ease in the back half, supporting earnings acceleration and a more compelling catalyst path as the year progresses. With the stock still trading at levels he views as attractive and the price target unchanged at $172, he believes investors are being compensated for near‑term volatility and thus maintains a Buy recommendation on PG.
In another report released on July 16, J.P. Morgan also maintained a Buy rating on the stock with a $162.00 price target.